The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Aveanna Healthcare (AVAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out. Aveanna Healthcare is a member of the Medical sector. This group includes 1000 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Aveanna Healthcare is currently sporting a Zacks Rank of #2 (Buy). Over the past 90 days, the Zacks Consensus Estimate for AVAH's full-year earnings has moved 1600% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive. Based on the latest available data, AVAH has gained about 31.3% so far this year. At the same time, Medical stocks have lost an average of 7.2%. This means that Aveanna Healthcare is performing better than its sector in terms of year-to-date returns. Another stock in the Medical sector, HCA Healthcare (HCA), has outperformed the sector so far this year. The stock's year-to-date return is 28.4%. For HCA Healthcare, the consensus EPS estimate for the current year has increased 1.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy). To break things down more, Aveanna Healthcare belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 17 individual companies and currently sits at #62 in the Zacks Industry Rank. This group has gained an average of 5.8% so far this year, so AVAH is performing better in this area. In contrast, HCA Healthcare falls under the Medical - Hospital industry. Currently, this industry has 5 stocks and is ranked #53. Since the beginning of the year, the industry has moved +21.8%. Investors with an interest in Medical stocks should continue to track Aveanna Healthcare and HCA Healthcare. These stocks will be looking to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues Aveanna Healthcare Holdings Inc. (AVAH):Free Stock Analysis Report HCA Healthcare, Inc. (HCA):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...